Cargando...
Tocilizumab administration in COVID-19 patients: Water on the fire or gasoline?
Tocilizumab is widely being used to treat COVID-19. Although reducing systemic inflammation, it also increases the risk for secondary infections as a result of the immunosuppression produced. We report the case of a 69-year-old patient admitted to the ICU with severe respiratory distress caused by C...
Gardado en:
| Publicado en: | Med Mycol Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826035/ https://ncbi.nlm.nih.gov/pubmed/33520634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mmcr.2021.01.002 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|